# Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment

Study · id `cardio:ct-nct06238024` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06238024](<https://clinicaltrials.gov/study/NCT06238024>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06238024

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 108 participants.

## Technical summary

Registry record NCT06238024. Randomized; quadruple masking; primary purpose treatment. Start 2024-02-02 (actual); primary completion 2024-06-25 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 108 participants (enrolled count; ClinicalTrials.gov record NCT06238024, source copy `cardio:ctgov-nct06238024-2024-09-25`, retrieved 2026-10-26)
- Started: 2024-02-02 (actual) (ClinicalTrials.gov record NCT06238024, source copy `cardio:ctgov-nct06238024-2024-09-25`, retrieved 2026-10-26)
- Primary completion: 2024-06-25 (actual) (ClinicalTrials.gov record NCT06238024, source copy `cardio:ctgov-nct06238024-2024-09-25`, retrieved 2026-10-26)
- Completion: 2024-09-22 (actual) (ClinicalTrials.gov record NCT06238024, source copy `cardio:ctgov-nct06238024-2024-09-25`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06238024, source copy `cardio:ctgov-nct06238024-2024-09-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06238024-2024-09-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment
- Acronym: IRIS
- Condition: Interleukin-6
- Condition: Ischemic Stroke
- Condition: Endovascular Treatment
- Intervention (Drug): Tocilizumab
- Intervention (Drug): NaCl 0.9% 100ml
- Lead sponsor: Suzhou Municipal Hospital of Anhui Province
- Lead sponsor class: OTHER
- Collaborator: Xuanwu Hospital, Beijing
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as a collaborator: Xuanwu Hospital, Beijing (`cardio:org-xuanwu-hospital-beijing`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of IL-6 receptor inhibition on infarct volume after endovascular treatment for ischaemic stroke: a phase 2, randomised, placebo-controlled trial (`cardio:pubmed-41687453`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: fb10f0868e6124cd6d0e33fb4d46b06ccbee0308b18d14db984ed5bedcadf96c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
